Cholangiocarcinoma (bile duct cancer) · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | standard |
|---|---|
| Linked regimen | None |
| ID | IND-OPISTHORCHIS-CHOLANGIO-PREVENTION-TREATMENT |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-18 | pending_clinical_signoff |
| Diseases | DIS-CHOLANGIOCARCINOMA |
| Sources | SRC-IARC-MONO-100B-2012 SRC-NCCN-HCC-2025 |
Notes
STUB — O. viverrini prevention anchor. v0.2-A continuation. Praziquantel REG-* and TEST-CA19-9 / TEST-LIVER-US pending.
Used By
Indication
IND-OPISTHORCHIS-CHOLANGIO-PREVENTION-OBSERVATION- IND-OPISTHORCHIS-CHOLANGIO-PREVENTION-OBSERVATION